As per our report, the size of the Middle East & Africa Contraceptives Market was worth USD 2.60 billion in 2022 and estimated to reach USD 3.61 billion by the end of 2027, with a growing potential of 6.742%.
For the critical family procedures, adopting new permanent contraceptives is the primary driver in low-income countries.
An increasing need for population control and the growing incidence of STDs are two of the most impact rendering drivers of this industry. Moreover, the implementation of activities targeted at controlling unwanted pregnancy-associated healthcare spending and a growing level of awareness among the users should ensure positive market growth in the coming years.
The factors influencing the growth of the Middle East and Africa market are the growing development of capable female contraceptive devices and drugs, advancement in technologies, increasing number of initiatives from government and NGOs to promote contraceptives.
Side effects associated with the use of contraceptive devices and drugs and the rising prevalence of infertility are the restraints hampering the market's growth.
This research report on the MEA contraceptives market has been segmented & sub-segmented into the following categories:
By Drug Type:
By Medical Devices:
By End User:
Geographically, the usage of contraceptives is increasing in Saudi Arabia, and this country has high fertility and birth rates due to the growing population and large families. The perception of men using contraceptives is changing drastically, and they show acceptance towards use for birth spacing, which is estimated to boost the Saudi Arabia contraceptives market.
The African contraceptives market is estimated to register a healthy CAGR during the forecast period. The awareness regarding the usage of contraceptives in this region is growing significantly. Every year around 1.4 million unsafe abortion takes place among the girls aged 15-19 in Africa. State of Africa women report of 2018 says that the total fertility rate of the African continent is the highest in the world. The family planning organization noted that Africa recorded the most significant gains of modern contraceptive use in 2020.
KEY MARKET PLAYERS:
Companies playing a noteworthy role in the MEA contraceptives market profiled in this report are Bayer HealthCare AG, Teva Pharmaceutical Industries Limited, Medisafe Distribution Inc, Pace Pharmaceuticals Inc., Medicines360, Church & Dwight, Co., Inc., Actavis, Inc., CooperSurgical, Inc., Merck & Co., Inc., Reckitt Benckiser plc, Mayer Laboratories, Inc., and Pfizer, Inc.
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 By Drug type
5.1.1 Contraceptive pills
5.1.2 Topical contraceptives
5.1.3 Contraceptive injectable
5.1.4 Others (contraceptive gels, jellies and creams)
5.2 By Medical Devices
5.2.1 Male contraceptive devices
5.2.2 Female contraceptive devices
188.8.131.52 Female condoms
184.108.40.206 Intrauterine devices
220.127.116.11 Contraceptive sponges
18.104.22.168 Contraceptive diaphragms
22.214.171.124 Contraceptive patches
126.96.36.199 Subdermal contraceptive implants
188.8.131.52 Non-surgical permanent contraceptive devices
6. Geographical Analysis
7.1 PESTLE analysis
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Bayer HealthCare AG
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Teva Pharmaceutical Industries Limited
8.3 Medisafe Distribution Inc
8.4 Pace Pharmaceuticals Inc
8.6 Church & Dwight, Co., Inc.
8.7 Actavis, Inc
8.9 Merck & Co., Inc
8.10 Reckitt Benckiser plc
8.11 Mayer Laboratories, Inc
8.12 Pfizer, Inc
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Oppurtunities
a) List of Tables
b) List of Figures
Talk to our analyst and get customised report done according to your research needs
Check if you can avail any discount. Submit your details and our team will get back to you.
Request to avail a free sample report that reflects this market and its growth.